Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel epipodophyllotoxin derivatives with excellent antitumor activity

July 28, 1999

Asmarine A and B: novel cytotoxic alkaloids produced by marine organism

July 28, 1999

Kinetek initiates development of ILK and PKB inhibitors for cancer therapy

July 28, 1999

Bayer presents new anticancer compounds that inhibit Raf kinase

July 27, 1999

Paxene approved for E.U. marketing; Paxoral shows positive results in phase I

July 26, 1999

Valentis initiates phase I/II trial of IL-12 gene therapy

July 26, 1999

Extremely potent cytotoxic cryptophycin analogue discovered at Lilly

July 23, 1999

CDK2-inhibitory purine derivatives with potential in cancer therapy

July 23, 1999

UBCLE: a new protein discovered at Incyte; antagonists useful for cancer, etc.

July 23, 1999

Genta's BCL-2 antisense claims allowed in U.S.

July 23, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...